Cargando…

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder

OBJECTIVE: Some clinical studies have found alterations in the levels of serum brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) after applying antidepressant treatment in patients with major depressive disorder (MDD). We evaluated the serum BDNF and GDN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Young-Min, Lee, Bun-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111227/ https://www.ncbi.nlm.nih.gov/pubmed/29945425 http://dx.doi.org/10.30773/pi.2018.03.31

Ejemplares similares

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
por: Lee, Jeong-Ok, et al.
Publicado: (2018)

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction
por: Tang, Xiaowei, et al.
Publicado: (2019)

Serum BDNF Levels in Relation to Illness Severity, Suicide Attempts, and Central Serotonin Activity in Patients with Major Depressive Disorder: A Pilot Study
por: Park, Young-Min, et al.
Publicado: (2014)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

The serum protein levels of the tPA–BDNF pathway are implicated in depression and antidepressant treatment
por: Jiang, H, et al.
Publicado: (2017)

Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
por: Lindholm, Jesse S. O., et al.
Publicado: (2014)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
por: An, Jing, et al.
Publicado: (2019)

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients
por: Martín-López, Luis M., et al.
Publicado: (2011)

Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
por: Ho, Siew Ching, et al.
Publicado: (2017)

Changes in Plasma TPH2, GDNF, Trk-b, BDNF, and proBDNF in People Who Died by Suicide
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Minor Immunoreactivity in GDNF-, BDNF-, or NT-3-Treated Substantia Nigra Allografts
por: Shinoda, Masaki, et al.
Publicado: (1997)

BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia
por: Turkmen, Betul Aslan, et al.
Publicado: (2021)

The Role of Metals in the Neuroregenerative Action of BDNF, GDNF, NGF and Other Neurotrophic Factors
por: Nicoletti, Vincenzo Giuseppe, et al.
Publicado: (2022)

Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy
por: Zheng, Wei, et al.
Publicado: (2020)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
por: Park, Young-Min, et al.
Publicado: (2016)

Noncontinuous use of antidepressant in adults with major depressive disorders – a retrospective cohort study
por: Yau, Wai-Yin, et al.
Publicado: (2014)

Associations of Serum Serotonin Levels with 12-week and 12-month Remission in Patients with Depressive Disorders
por: Choi, Wonsuk, et al.
Publicado: (2022)

Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance
por: Ferrini, Francesco, et al.
Publicado: (2021)

BDNF rs962369 Is Associated with Major Depressive Disorder
por: Bednářová, Aneta, et al.
Publicado: (2023)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy
por: Xu, Dong, et al.
Publicado: (2023)

Alterations of Serum Levels of BDNF-Related miRNAs in Patients with Depression
por: Li, You-Jie, et al.
Publicado: (2013)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder
por: Chen, Suzhen, et al.
Publicado: (2021)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Brain grey matter volume alterations associated with antidepressant response in major depressive disorder
por: Liu, Jia, et al.
Publicado: (2017)

Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with Major Depression
por: Guilloux, Jean-Philippe, et al.
Publicado: (2011)

The Influence of Neurotrophic Factors BDNF and GDNF Overexpression on the Functional State of Mice and Their Adaptation to Audiogenic Seizures
por: Kustova, Angelina O., et al.
Publicado: (2022)

Suicide and Neurotrophin Factors: A Systematic Review of the Correlation between BDNF and GDNF and Self-Killing
por: De Simone, Stefania, et al.
Publicado: (2022)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Effects of BDNF Polymorphisms on Antidepressant Action
por: Tsai, Shih-Jen, et al.
Publicado: (2010)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)

Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment
por: Mellon, S H, et al.
Publicado: (2016)

Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response
por: Jang, Byong-Su, et al.
Publicado: (2008)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Eight‐week antidepressant treatment reduces functional connectivity in first‐episode drug‐naïve patients with major depressive disorder
por: Li, Le, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jap34597tglitptr5gk95bnb0b